Marc E. Horowitz

7.8k total citations · 2 hit papers
98 papers, 5.9k citations indexed

About

Marc E. Horowitz is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Neurology. According to data from OpenAlex, Marc E. Horowitz has authored 98 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 34 papers in Genetics and 29 papers in Neurology. Recurrent topics in Marc E. Horowitz's work include Glioma Diagnosis and Treatment (32 papers), Neuroblastoma Research and Treatments (26 papers) and Sarcoma Diagnosis and Treatment (25 papers). Marc E. Horowitz is often cited by papers focused on Glioma Diagnosis and Treatment (32 papers), Neuroblastoma Research and Treatments (26 papers) and Sarcoma Diagnosis and Treatment (25 papers). Marc E. Horowitz collaborates with scholars based in United States, Hungary and Canada. Marc E. Horowitz's co-authors include Leonard H. Wexler, Robert A. Sanford, Larry E. Kun, Seth M. Steinberg, Raymond K. Mulhern, Michael E. Cohen, Mary P. Andrich, Henry S. Friedman, Peter C. Burger and Patricia K. Duffner and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Marc E. Horowitz

97 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy

1995 866 citations Mary P. Andrich, Marc E. Horowitz et al. profile →
Postoperative Chemotherapy and Delayed Radiation in Children Less Than Three Years of Age with Malignant Brain Tumors

1993 593 citations Patricia K. Duffner, Marc E. Horowitz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc E. Horowitz United States	41	1.9k	1.6k	1.3k	1.2k	1.2k	98	5.9k
Edward C. Halperin United States	41	1.6k 0.8×	2.3k 1.4×	953 0.7×	830 0.7×	807 0.7×	187	5.7k
Lorenza Gandola Italy	37	1.9k 1.0×	1.3k 0.8×	1.0k 0.8×	1.6k 1.3×	851 0.7×	148	5.2k
G. Denman Hammond United States	53	1.2k 0.6×	1.9k 1.2×	1.9k 1.4×	1.2k 1.0×	1.8k 1.6×	132	7.5k
Olivier Hartmann France	49	1.1k 0.6×	1.1k 0.7×	2.9k 2.2×	1.5k 1.2×	1.8k 1.6×	209	6.9k
CR Pinkerton United Kingdom	38	1.4k 0.7×	468 0.3×	1.3k 0.9×	1.5k 1.3×	999 0.9×	157	5.2k
Maura Massimino Italy	41	1.7k 0.9×	2.5k 1.5×	1.5k 1.1×	1.0k 0.9×	1.5k 1.3×	346	6.2k
Catherine A. Billups United States	48	2.5k 1.3×	754 0.5×	1.2k 0.9×	1.8k 1.5×	2.0k 1.7×	165	6.0k
Stewart Goldman United States	48	1.2k 0.6×	3.0k 1.9×	2.1k 1.6×	903 0.8×	2.4k 2.1×	178	6.7k
Ira J. Dunkel United States	48	1.9k 1.0×	3.0k 1.9×	1.7k 1.3×	1.6k 1.3×	1.7k 1.4×	248	7.7k
Richard L. Heideman United States	46	1.3k 0.7×	3.1k 1.9×	1.9k 1.4×	935 0.8×	1.8k 1.5×	117	5.5k

Countries citing papers authored by Marc E. Horowitz

Since Specialization

Citations

This map shows the geographic impact of Marc E. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc E. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc E. Horowitz more than expected).

Fields of papers citing papers by Marc E. Horowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc E. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc E. Horowitz. The network helps show where Marc E. Horowitz may publish in the future.

Co-authorship network of co-authors of Marc E. Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Marc E. Horowitz. A scholar is included among the top collaborators of Marc E. Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc E. Horowitz. Marc E. Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Poplack, David G., Michael Fordis, Wendy Landier, et al.. (2014). Childhood cancer survivor care: development of the Passport for Care. Nature Reviews Clinical Oncology. 11(12). 740–750. 58 indexed citations

Frugé, Ernest, Donald H. Mahoney, David G. Poplack, & Marc E. Horowitz. (2010). Leadership: “They Never Taught Me This in Medical School”. Journal of Pediatric Hematology/Oncology. 32(4). 304–308. 20 indexed citations

Duffner, Patricia K., Jeffrey P. Krischer, Marc E. Horowitz, et al.. (1998). Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: A pediatric oncology group study. Annals of Neurology. 44(3). 313–316. 86 indexed citations

Blaney, Susan M., Peter C. Phillips∥, Roger J. Packer, et al.. (1996). Phase II evaluation of topotecan for pediatric central nervous system tumors. Cancer. 78(3). 527–531. 1 indexed citations

Wexler, Leonard H., Mary P. Andrich, D Venzon, et al.. (1996). Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.. Journal of Clinical Oncology. 14(2). 362–372. 171 indexed citations

Duffner, Patricia K., Peter C. Burger, Michael E. Cohen, et al.. (1994). Desmoplastic Infantile Gangliogliomas. Neurosurgery. 34(4). 583–589. 56 indexed citations

Gajjar, Amar, Richard L. Heideman, Edward H. Kovnar, et al.. (1993). Response of Pediatric Low Grade Gliomas to Chemotherapy. Pediatric Neurosurgery. 19(3). 113–120. 36 indexed citations

Smith, Malcolm A., Peter C. Adamson, Frank M. Balis, et al.. (1992). Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.. Journal of Clinical Oncology. 10(11). 1666–1673. 119 indexed citations

Friedman, Jeffrey M., et al.. (1992). Expression of the cholecystokinin gene in pediatric tumors.. Proceedings of the National Academy of Sciences. 89(13). 5819–5823. 17 indexed citations

10.

Horowitz, Marc E. & Philip A. Pizzo. (1991). Solid tumors in children. Saunders eBooks.

11.

Friedman, Henry S., Marc E. Horowitz, & W. Jerry Oakes. (1991). Tumors of the Central Nervous System: Improvement in Outcome Through a Multimodality Approach. Pediatric Clinics of North America. 38(2). 381–391. 7 indexed citations

12.

Schell, Michael J., et al.. (1989). Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation.. Journal of Clinical Oncology. 7(6). 754–760. 165 indexed citations

13.

Meyer, William H., Peter J. Houghton, Marc E. Horowitz, et al.. (1989). Use of Investigational Drugs as Initial Therapy for Childhood Solid Tumors. Hämatologie und Bluttransfusion. 32. 141–148. 4 indexed citations

14.

Horowitz, Marc E., et al.. (1989). Purpura Fulminans. Clinical Pediatrics. 28(2). 95–98. 10 indexed citations

15.

Bader, Judith L., Marc E. Horowitz, E. Blake Watkins, et al.. (1989). Intensive combined modality therapy of small round cell and undifferentiated sarcomas in children and young adults: local control and patterns of failure. Radiotherapy and Oncology. 16(3). 189–201. 19 indexed citations

16.

Mulhern, Raymond K., Marc E. Horowitz, Edward H. Kovnar, et al.. (1989). Neurodevelopmental status of infants and young children treated for brain tumors with preirradiation chemotherapy.. Journal of Clinical Oncology. 7(11). 1660–1666. 59 indexed citations

17.

Goren, Marshall P., Reba K. Wright, Charles B. Pratt, et al.. (1987). Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.. PubMed. 47(5). 1457–60. 99 indexed citations

18.

Flood, Patrick M., D B Murphy, Marc E. Horowitz, et al.. (1985). A monoclonal antibody that recognizes an Ly-6-linked antigen inhibits the generation of functionally active T cell subsets.. The Journal of Immunology. 135(1). 63–72. 18 indexed citations

19.

Horowitz, Marc E., et al.. (1980). Misonidazole distribution in a rat RT-9 tumor model. 22(3). 176. 2 indexed citations

20.

Janeway, Charles A., et al.. (1979). Lipid-modified antigens. I. Specificity of guinea pig T lymphocyte responses and I-region restriction.. PubMed. 122(4). 1482–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact